How much is life worth? The $440 billion question
Monday, June 29, 2009 - 15:49
in Health & Medicine
The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S. that needs to be addressed by the oncology community, according to a commentary published online June 29 in the Journal of the National Cancer Institute.